Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference
Edwards Lifesciences (NYSE: EW), a global leader in patient-focused innovations for structural heart disease and critical care monitoring, has announced its participation in the 2024 Wells Fargo Healthcare Conference. The event is scheduled for Thursday, September 5, 2024, with CEO Bernard Zovighian and CFO Scott Ullem set to present at 10:15 a.m. ET.
A live webcast of the presentation will be available on the company's investor relations website, with an archived version accessible later the same day. This presentation offers an opportunity for investors and stakeholders to gain insights into Edwards Lifesciences' strategies and market position in the healthcare industry.
Edwards Lifesciences (NYSE: EW), leader globale nelle innovazioni focalizzate sul paziente per le malattie cardiache strutturali e il monitoraggio critico della cura, ha annunciato la sua partecipazione alla Conferenza Sanitaria Wells Fargo 2024. L'evento è programmato per giovedì 5 settembre 2024, con il CEO Bernard Zovighian e il CFO Scott Ullem che presenteranno alle 10:15 a.m. ET.
Un webcast live della presentazione sarà disponibile sul sito web delle relazioni con gli investitori della compagnia, con una versione archiviata accessibile successivamente nello stesso giorno. Questa presentazione offre un'opportunità per investitori e interessati di ottenere informazioni sulle strategie di Edwards Lifesciences e sulla sua posizione di mercato nell'industria sanitaria.
Edwards Lifesciences (NYSE: EW), líder global en innovaciones centradas en el paciente para enfermedades cardíacas estructurales y monitoreo de cuidados críticos, ha anunciado su participación en la Conferencia de Salud Wells Fargo 2024. El evento está programado para el jueves 5 de septiembre de 2024, con el CEO Bernard Zovighian y el CFO Scott Ullem presentando a las 10:15 a.m. ET.
Se ofrecerá un webcast en vivo de la presentación en el sitio web de relaciones con inversores de la compañía, con una versión archivada accesible más tarde el mismo día. Esta presentación ofrece una oportunidad para que inversores y partes interesadas obtengan información sobre las estrategias de Edwards Lifesciences y su posición en el mercado de la salud.
에드워즈 라이프사이언스 (NYSE: EW)는 구조적 심장 질환과 중환자 모니터링을 위한 환자 중심 혁신의 글로벌 리더로서 2024 웰스파고 헬스케어 컨퍼런스에 참여할 것이라고 발표했습니다. 이 행사는 2024년 9월 5일 목요일에 예정되어 있으며, CEO인 바나드 조비기안과 CFO인 스콧 윌렘이 오전 10시 15분 ET에 발표할 예정입니다.
발표의 실시간 웹캐스트는 회사의 투자자 관계 웹사이트에서 제공되며, 동일한 날 나중에 아카이브된 버전도 접근할 수 있습니다. 이 발표는 투자자와 이해관계자들이 에드워즈 라이프사이언스의 전략 및 헬스케어 산업 내 시장 위치에 대한 통찰력을 얻을 기회를 제공합니다.
Edwards Lifesciences (NYSE: EW), un leader mondial dans les innovations axées sur le patient pour les maladies cardiaques structurelles et le monitoring des soins critiques, a annoncé sa participation à la Conférence Santé Wells Fargo 2024. L'événement est prévu pour le jeudi 5 septembre 2024, avec le directeur général Bernard Zovighian et le directeur financier Scott Ullem qui présenteront à 10h15 ET.
Un webinaire en direct de la présentation sera disponible sur le site web des relations investisseur de l'entreprise, avec une version archivées accessible plus tard dans la journée. Cette présentation offre aux investisseurs et aux parties prenantes l'opportunité d'obtenir des informations sur les stratégies d'Edwards Lifesciences et sa position sur le marché dans le secteur de la santé.
Edwards Lifesciences (NYSE: EW), ein globaler Marktführer in patientenorientierten Innovationen für strukturelle Herzerkrankungen und kritisches Monitoring, hat seine Teilnahme an der Wells Fargo Healthcare Conference 2024 angekündigt. Die Veranstaltung findet am Donnerstag, dem 5. September 2024, statt, wobei CEO Bernard Zovighian und CFO Scott Ullem um 10:15 Uhr ET präsentieren werden.
Ein Live-Webcast der Präsentation wird auf der Investor-Relations-Website des Unternehmens verfügbar sein, mit einer später am selben Tag abrufbaren archivierten Version. Diese Präsentation bietet Investoren und Interessierten die Möglichkeit, Einblicke in die Strategien und die Marktposition von Edwards Lifesciences in der Gesundheitsindustrie zu gewinnen.
- None.
- None.
Bernard Zovighian, chief executive officer, and Scott Ullem, chief financial officer, are scheduled to present at 10:15 a.m. ET. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.
About Edwards Lifesciences
Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. We are driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape. For more information, visit Edwards.com and follow us on Facebook, Instagram, LinkedIn, X and YouTube.
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240821162139/en/
Media Contact: Amy Hytowitz, 949-250-5070
Investor Contact: Mark Wilterding, 949-250-6826
Source: Edwards Lifesciences Corporation
FAQ
When is Edwards Lifesciences (EW) presenting at the 2024 Wells Fargo Healthcare Conference?
Who will be representing Edwards Lifesciences (EW) at the 2024 Wells Fargo Healthcare Conference?
How can I watch Edwards Lifesciences' (EW) presentation at the 2024 Wells Fargo Healthcare Conference?
What is Edwards Lifesciences' (EW) primary focus in the healthcare industry?
